Nasdaq; Exchange Act Registration. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Market, and the Company has taken no action designed to terminate, or any action reasonably likely to have the effect of terminating, the registration of the Common Stock under the Exchange Act or delisting the Common Stock from The Nasdaq Global Market, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. The Company has complied in all material respects with the applicable requirements of Nasdaq for the maintenance of inclusion of the Common Stock on The Nasdaq Global Market. The Company has filed an application to include the Shares on The Nasdaq Global Market.
Appears in 3 contracts
Samples: Placement Agency Agreement (BMP Sunstone CORP), Subscription Agreement (BMP Sunstone CORP), Subscription Agreement (Beijing Med Pharm Corp)
Nasdaq; Exchange Act Registration. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Market, and the Company has taken no action designed to terminate, or any action reasonably likely to have the effect of terminating, the registration of the Common Stock under the Exchange Act or delisting the Common Stock from The Nasdaq Global Market, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. The Company has complied in all material respects with the applicable requirements of Nasdaq for the maintenance of inclusion of the Common Stock on The Nasdaq Global Market. The Company has filed an application to include the Shares Notes on The Nasdaq Global Market.
Appears in 2 contracts
Samples: Subscription Agreement (BMP Sunstone CORP), Placement Agency Agreement (BMP Sunstone CORP)
Nasdaq; Exchange Act Registration. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Market, and the Company has taken no action designed to terminate, or any action reasonably likely to have the effect of terminating, the registration of the Common Stock under the Exchange Act or delisting the Common Stock from The Nasdaq Global Market, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. The Company has complied in all material respects with the applicable requirements of Nasdaq for the maintenance of inclusion of the Common Stock on The Nasdaq Global Market. The Company has filed an application to include the Shares Securities on The Nasdaq Global Market.
Appears in 1 contract
Samples: Placement Agency Agreement (Beijing Med Pharm Corp)
Nasdaq; Exchange Act Registration. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed accepted for quotation on The the Nasdaq Global Market, and the Company has taken no action designed to terminateto, or any action reasonably likely to have the effect of terminatingof, termination the registration of the Common Stock under the Exchange Act or delisting the Common Stock from The the Nasdaq Global Market, nor has the Company received any notification that the Commission or Nasdaq the NASD is contemplating terminating such registration or listing. The Company has complied in all material respects with the applicable requirements of the Nasdaq Global Market for the maintenance of inclusion of the Common Stock on The Nasdaq Global Marketthereon. The Company has filed an application to include the Shares and Warrant Shares on The the Nasdaq Global Market.
Appears in 1 contract
Samples: Placement Agency Agreement (Cytori Therapeutics, Inc.)
Nasdaq; Exchange Act Registration. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed accepted for quotation on The the Nasdaq Global Market, and the Company has taken no action designed to terminateto, or any action reasonably likely to have the effect of terminatingof, termination the registration of the Common Stock under the Exchange Act or delisting the Common Stock from The the Nasdaq Global Market, nor has the Company received any notification that the Commission or Nasdaq the NASD is contemplating terminating such registration or listing. The Company has complied in all material respects with the applicable requirements of the Nasdaq Global Market for the maintenance of inclusion of the Common Stock on The Nasdaq Global Marketthereon. The Company has filed an application to include the Shares on The the Nasdaq Global Market.
Appears in 1 contract
Samples: Placement Agency Agreement (Cytori Therapeutics, Inc.)